Associated Papers
Ruxolitinib Plus Decitabine Effectively Treats Myelodysplastic Syndrome/Myeloproliferative Neoplasm, Unclassifiable, by Decreasing the Variant Allele Frequency of KRAS.
Luo S et al.
Oncotargets and Therapy, 2020
Select a paper to view details